NASDAQ
Ligand Pharmaceuticals Incorporated (LGND) has a free cash flow growth of 5.73% as of Friday, May 29, 2026. This represents a 88.66% decrease compared to its 12-month average of 50.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.